3 Results for "

AcBut

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "AcBut" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109539
CAS No.: 220578-59-6
Purity:  98.0%
Research Areas:  

Cancer

Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) consisting of a humanized immunoglobulin (IgG4) antibody directed against CD33 that is conjugated to the cytotoxic agent Calicheamicin (HY-19609). The antibody portion is Gemtuzumab (HY-P99971), and the drug-linker conjugate for ADC is N-Ac-γ-Calicheamicin-AcBut-NHS ester (HY-103688). Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-103688
CAS No.: 174885-02-0
Purity:  95.62%
Target:  

ADC Payloads

Research Areas:  

Cancer

AcBut-N-Ac-γ-Calicheamicin is an ADC cytotoxic payload that induces cell cycle arrest and apoptosis by causing DNA double-strand breaks. AcBut-N-Ac-γ-Calicheamicin is primarily used in the synthesis of antibody-drug conjugates (ADC) and holds promise for research in the field of cancer, including acute lymphoblastic leukemia (ALL) and other hematological malignancies .
loading...
    loading...
Cat. No.: HY-132261
CAS No.: 65623-82-7
Purity:  98.07%
Synonyms: 4-(4-Acetyl-phenoxy)-butyric acid
Target:  

ADC Linkers

Research Areas:  

Cancer

AcBut (4-(4-Acetyl-phenoxy)-butyric acid) is a cleavable linker for Ozogamicin synthesis, and Ozogamicin is a drug-linker conjugate for ADC .
loading...
    loading...